Collegium Pharmaceutical Unveils 2025 Financial Projections
2 days ago · Collegium Pharmaceutical announced its 2025 financial guidance, projecting product revenues between $735 and $750 million, with a focus on Jornay PM expected to exceed $135 million in net revenue.
Collegium Pharmaceutical’s Promising Growth and Undervalued ...
1 day ago · In a report released today, Serge Belanger from Needham upgraded Collegium Pharmaceutical (COLL – Research Report) to a Buy, with a price target of $46.00. Discover outperforming stocks and ...
Collegium's Revenue Outlook And CNS Expansion Signal ...
19 hours ago · Needham analyst Serge Belanger upgraded Collegium Pharmaceutical, Inc. COLL to Buy from Hold, with a price forecast of $46.. Recently, Collegium provided 2025 guidance, expecting a top-line of ...
Collegium Pharmaceutical, Inc. Provides 2025 Financial ...
3 days ago · Collegium Pharmaceutical forecasts 2025 product revenues of $735-$750 million, with adjusted EBITDA of $435-$450 million. Collegium Pharmaceutical, Inc. has provided its financial guidance for ...
Collegium Pharma spikes after 2025 outlook - Seeking Alpha
2 days ago · spawns. Collegium Pharmaceutical (NASDAQ:COLL) traded higher on Wednesday after the pain therapy developer provided its 2025 financial outlook along with a business update.The Stoughton ...
Collegium Pharmaceutical, Inc. (COLL) Stock Price, News ...
Find the latest Collegium Pharmaceutical, Inc. (COLL) stock quote, history, news and other vital information to help you with your stock trading and investing.
COLL Stock Price | Collegium Pharmaceutical Inc ... - MarketWatch
4 days ago · COLL | Complete Collegium Pharmaceutical Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Collegium Pharmaceutical, Inc. (COLL) - Stock Analysis
4 days ago · Get a real-time Collegium Pharmaceutical, Inc. (COLL) stock price quote with breaking news, financials, statistics, charts and more.
Collegium Pharmaceutical, Inc. (COLL) Latest Stock News ...
Get the latest Collegium Pharmaceutical, Inc. (COLL) stock news and headlines to help you in your trading and investing decisions.
Collegium Announces $35 Million Accelerated Share Repurchase ...
STOUGHTON, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of...
- Some results have been removed